The longer term downtrend has been broken, and price went through some sideways accumulation.
Now, I'm waiting for price to pull back to at least the 0.5 fib (done) but no further than the 0.236 fib. If price reverses and heads back up, without going below the 0.236 fib, I'll start buying in when price reaches the the 0.5 fib.
Target = 1.618 fib level for ~57%...
Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. The company is advancing five clinical, preclinical and discovery programs: IK-007, an EP4 receptor antagonist; IK-175, an AHR antagonist; IK-412, a kynurenine-degrading enzyme Kynase;...